Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer’s disease

The aim of the present study was to investigate the potential clinical application of the genetic marker microRNA (miRNA)-210 in the cerebrospinal fluid (CSF) and serum of patients with Alzheimer’s disease (AD). The enrolled patients were divided into the mild cognitive impairment (MCI) and AD group...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHU, YAN, LI, CHENGSHAN, SUN, AICHEN, WANG, YUANYE, ZHOU, SHENGNIAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316946/
https://www.ncbi.nlm.nih.gov/pubmed/25667669
http://dx.doi.org/10.3892/etm.2015.2179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316946/
https://www.ncbi.nlm.nih.gov/pubmed/25667669
http://dx.doi.org/10.3892/etm.2015.2179

Ejemplares similares